PubMed

Effective maintenance treatment of reflux esophagitis with low-dose lansoprazole. A randomized, double-blind, placebo-controlled trial.

Robinson M, Lanza F, Avner D, Haber M.

Ann Intern Med. 1996 May 15;124(10):859-67.PMID: 8610914 [PubMed - indexed for MEDLINE]Related articlesFree article

Daily low-dose versus alternate day full-dose lansoprazole in the maintenance treatment of reflux esophagitis.

Baldi F, Morselli-Labate AM, Cappiello R, Ghersi S; Italian Lansoprazole Study Group.

Am J Gastroenterol. 2002 Jun;97(6):1357-64.PMID: 12094850 [PubMed - indexed for MEDLINE]Related articles

Maintenance of healed erosive esophagitis: a randomized six-month comparison of esomeprazole twenty milligrams with lansoprazole fifteen milligrams.

Devault KR, Johanson JF, Johnson DA, Liu S, Sostek MB.

Clin Gastroenterol Hepatol. 2006 Jul;4(7):852-9. Epub 2006 May 6.PMID: 16682260 [PubMed - indexed for MEDLINE]Related articles

A placebo-controlled dose-ranging study of lansoprazole in the management of reflux esophagitis.

Earnest DL, Dorsch E, Jones J, Jennings DE, Greski-Rose PA.

Am J Gastroenterol. 1998 Feb;93(2):238-43.PMID: 9468251 [PubMed - indexed for MEDLINE]Related articles

Lansoprazole prevents recurrence of erosive reflux esophagitis previously resistant to H2-RA therapy. The Lansoprazole Maintenance Study Group.

Sontag SJ, Kogut DG, Fleischmann R, Campbell DR, Richter J, Haber M.

Am J Gastroenterol. 1996 Sep;91(9):1758-65.PMID: 8792694 [PubMed - indexed for MEDLINE]Related articles

The new proton pump inhibitor esomeprazole is effective as a maintenance therapy in GERD patients with healed erosive oesophagitis: a 6-month, randomized, double-blind, placebo-controlled study of efficacy and safety.

Vakil NB, Shaker R, Johnson DA, Kovacs T, Baerg RD, Hwang C, D'Amico D, Hamelin B.

Aliment Pharmacol Ther. 2001 Jul;15(7):927-35.PMID: 11421866 [PubMed - indexed for MEDLINE]Related articlesFree article

Esomeprazole once daily for 6 months is effective therapy for maintaining healed erosive esophagitis and for controlling gastroesophageal reflux disease symptoms: a randomized, double-blind, placebo-controlled study of efficacy and safety.

Johnson DA, Benjamin SB, Vakil NB, Goldstein JL, Lamet M, Whipple J, Damico D, Hamelin B.

Am J Gastroenterol. 2001 Jan;96(1):27-34. Erratum in: Am J Gastroenterol 2001 Mar;96(3):942. PMID: 11197282 [PubMed - indexed for MEDLINE]Related articles

A review of the clinical and economic impact of using esomeprazole or lansoprazole for the treatment of erosive esophagitis.

Raghunath AS, Green JR, Edwards SJ.

Clin Ther. 2003 Jul;25(7):2088-101. Review.PMID: 12946553 [PubMed - indexed for MEDLINE]Related articles

Lansoprazole 15 and 30 mg daily in maintaining healing and symptom relief in patients with reflux oesophagitis.

Hatlebakk JG, Berstad A.

Aliment Pharmacol Ther. 1997 Apr;11(2):365-72.PMID: 9146777 [PubMed - indexed for MEDLINE]Related articles

Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.

Sontag SJ, Kogut DG, Fleischmann R, Campbell DR, Richter J, Robinson M, McFarland M, Sabesin S, Lehman GA, Castell D.

Am J Gastroenterol. 1997 Mar;92(3):429-37.PMID: 9068463 [PubMed - indexed for MEDLINE]Related articles

Esomeprazole 20 mg and lansoprazole 15 mg in maintaining healed reflux oesophagitis: Metropole study results.

Lauritsen K, Devière J, Bigard MA, Bayerdörffer E, Mózsik G, Murray F, Kristjánsdóttir S, Savarino V, Vetvik K, De Freitas D, Orive V, Rodrigo L, Fried M, Morris J, Schneider H, Eklund S, Larkö A; Metropole study results.

Aliment Pharmacol Ther. 2003 Feb;17(3):333-41.PMID: 12562445 [PubMed - indexed for MEDLINE]Related articlesFree article

Efficacy and safety of lansoprazole in the treatment of erosive reflux esophagitis. The Lansoprazole Group.

Castell DO, Richter JE, Robinson M, Sontag SJ, Haber MM.

Am J Gastroenterol. 1996 Sep;91(9):1749-57.PMID: 8792693 [PubMed - indexed for MEDLINE]Related articles

Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis.

Castell DO, Kahrilas PJ, Richter JE, Vakil NB, Johnson DA, Zuckerman S, Skammer W, Levine JG.

Am J Gastroenterol. 2002 Mar;97(3):575-83.PMID: 11922549 [PubMed - indexed for MEDLINE]Related articles

Esomeprazole 20 mg and lansoprazole 15 mg in maintaining healed reflux oesophagitis: Metropole study results.

Lauritsen K, Devière J, Bigard MA, Bayerdörffer E, Mózsik G, Murray F, Kristjánsdóttir S, Savarino V, Vetvik K, De Freitas D, Orive V, Rodrigo L, Fried M, Morris J, Schneider H, Eklund S, Larkö A.

Aliment Pharmacol Ther. 2003 Feb;17 Suppl 1:24; discussion 25-7.PMID: 12614304 [PubMed - indexed for MEDLINE]Related articlesFree article

Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials.

Peura DA, Kovacs TO, Metz DC, Siepman N, Pilmer BL, Talley NJ.

Am J Med. 2004 Jun 1;116(11):740-8.PMID: 15144910 [PubMed - indexed for MEDLINE]Related articles

Long-term prevention of erosive or ulcerative gastro-oesophageal reflux disease relapse with rabeprazole 10 or 20 mg vs. placebo: results of a 5-year study in the United States.

Caos A, Breiter J, Perdomo C, Barth J.

Aliment Pharmacol Ther. 2005 Aug 1;22(3):193-202.PMID: 16091056 [PubMed - indexed for MEDLINE]Related articlesFree article

Double-blind comparison of lansoprazole 15 mg, lansoprazole 30 mg, and placebo in the maintenance of healed gastric ulcer.

Kovacs TO, Campbell D, Haber M, Rose P, Jennings DE, Richter J.

Dig Dis Sci. 1998 Apr;43(4):779-85.PMID: 9558034 [PubMed - indexed for MEDLINE]Related articles

Lansoprazole versus ranitidine in the maintenance treatment of reflux oesophagitis.

Gough AL, Long RG, Cooper BT, Fosters CS, Garrett AD, Langworthy CH.

Aliment Pharmacol Ther. 1996 Aug;10(4):529-39.PMID: 8853756 [PubMed - indexed for MEDLINE]Related articles

Lansoprazole heals erosive reflux oesophagitis in patients with Barrett's oesophagus.

Sontag SJ, Schnell TG, Chejfec G, Kurucar C, Karpf J, Levine G.

Aliment Pharmacol Ther. 1997 Feb;11(1):147-56.PMID: 9042987 [PubMed - indexed for MEDLINE]Related articles

Bedtime administration of lansoprazole does not modify its greater efficacy vs ranitidine in the acute and long-term treatment of duodenal ulcer. Results from a multicentre, randomised, double blind clinical trial.

Russo A, Dattilo M.

Ital J Gastroenterol Hepatol. 1997 Aug;29(4):312-9.PMID: 9476183 [PubMed - indexed for MEDLINE]Related articles